Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies
  1. Home
  2. Publications
  3. Supplementary Table S1 from A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies

Supplementary Table S1 from A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies

Authors:
  • ETErica S. Tsang
    Erica S. Tsang
  • RARahul R. Aggarwal
    Rahul R. Aggarwal
  • MDMallika S. Dhawan
    Mallika S. Dhawan
  • EBEmily K. Bergsland
    Emily K. Bergsland
  • EAEdwin A. Alvarez
    Edwin A. Alvarez
  • SCSusan Calabrese
    Susan Calabrese
  • RPRomain Pacaud
    Romain Pacaud
  • JGJose Garcia
    Jose Garcia
  • DFDelaire Fattah
    Delaire Fattah
  • STScott Thomas
    Scott Thomas
  • JGJennifer Grabowsky
    Jennifer Grabowsky
  • MMMark M. Moasser
    Mark M. Moasser

Open Access
Publisher website
Google Scholar
  • 4 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.22545363.v1
Abstract
No abstract available
Keywords
  • SOLID TUMOR
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.